ALK Monoklonaler Antikörper
ALK Monoklonal Antikörper für IHC, Indirect ELISA
Wirt / Isotyp
Maus / IgG2a
Getestete Reaktivität
human
Anwendung
IHC, Indirect ELISA
Konjugation
Unkonjugiert
CloneNo.
7G9E3
Kat-Nr. : 60321-1-PBS
Synonyme
Geprüfte Anwendungen
Produktinformation
60321-1-PBS bindet in IHC, Indirect ELISA ALK und zeigt Reaktivität mit human
| Getestete Reaktivität | human |
| Wirt / Isotyp | Maus / IgG2a |
| Klonalität | Monoklonal |
| Typ | Antikörper |
| Immunogen | ALK fusion protein Ag21493 |
| Vollständiger Name | anaplastic lymphoma receptor tyrosine kinase |
| Berechnetes Molekulargewicht | 1620 aa, 176 kDa |
| GenBank-Zugangsnummer | NM_004304 |
| Gene symbol | ALK |
| Gene ID (NCBI) | 238 |
| Konjugation | Unkonjugiert |
| Form | Liquid |
| Reinigungsmethode | Protein-A-Reinigung |
| Lagerungspuffer | PBS only |
| Lagerungsbedingungen | Store at -80°C. 20ul Größen enthalten 0,1% BSA. |
Hintergrundinformationen
ALK, also named as CD246, is a receptor tyrosine kinase (RTK) that belongs to the protein kinase superfamily. ALK is usually found in the nervous system and appears to play an important role in the normal development and function of the nervous system. ALK was originally identified as part of the NPM (Nucleophosmin)-ALK oncogenic fusion protein, resulting from the (2;5)(p23;q35) translocation that is frequently associated with anaplastic large-cell lymphoma (ALCL). The EML4 (echinoderm microtubule-associated protein-like 4)-ALK fusion protein have been described in non-small-cell lung cancer (NSCLC), this transforming fusion kinase is a promising candidate for a therapeutic target as well as for a diagnostic molecular marker in NSCLC (PMID: 17625570).



